Market Analysis
The global 3D Bioprinting Market Size is predicted to touch USD 1923.02 million at a 24.59% CAGR over the forecast period (2018-2023). 3D or three-dimensional bioprinting is the use of 3D printing like methods for combining biomaterials, growth factors and cells for fabricating biomedical parts which maximally imitate the natural tissue characteristic. It uses the method of layer-by-layer for depositing materials called bioinks for creating tissue-like structures which are used later in tissue engineering and medical fields. A wide range of biomaterials is covered under bioprinting. Various factors are propelling the 3D bioprinting market growth.
3D bioprinting market is expected to witness significant growth due to increasing use of 3D printing in drug discovery, cosmetic surgery, innovations in 3D bioprinting and technological advancement to manufacture customized products. Moreover, some other factors to drive the market growth are rising emphasis on research and development investment, rise in geriatric population and increasing need for organ transplantation.
On the contrary, socio-ethical concerns and limitations on biomaterial-based products are factors that may hinder the 3D bioprinting market growth over the forecast period.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/869
Key Players:
Leading players profiled in the 3D bioprinting market report include
- Cyfuse Biomedical K.K. (Japan)
- EnvisionTEC GmbH (Germany)
- Cellink AB (Sweden)
- Poietis (France)
- Stratasys Ltd. (U.S.)
- Aspect Biosystems Ltd. (Canada)
- Regenovo Biotechnology Co. Ltd. (China)
- Organovo Holdings Inc. (U.S.)
- Allevi (U.S.)
- FUJIFILM Wako Automation Corporation (U.S.)
- REGENHU Ltd. (Switzerland)
- Nano3D Biosciences Inc. (U.S.)
Key players have incorporated various strategies to create a niche in the market such as expansions, partnerships, and innovations.
3D Bioprinting Market Segmentation:
The MRFR report offers a wide segmental analysis of the 3D bioprinting market on the basis of end user, application, material, and technology.
Based on technology, the 3D bioprinting market is segmented into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting and microextrusion bioprinting. Of these, the microextrusion segment is predicted to have the largest share in the market over the forecast period owing to its wide applications in bioprinting.
Based on material, the 3D bioprinting market is segmented into extracellular matrices, hydrogels and living cells. Of these, the living cells segment will dominate the market over the forecast period.
Based on applications, the 3D bioprinting market is segmented into clinical applications and research applications. Of these, the research application segment will lead the market over the forecast period owing to its wide use in regenerative medicine and 3D cell culture.
Based on end users, the 3D bioprinting market is segmented into research organizations and academic institutes and pharmaceutical and biotechnology companies. Of these, the pharmaceutical and biotechnology companies’ segment will have the maximum share in the market over the forecast period.
Regional Analysis:
By region, the 3D bioprinting market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific, and the Middle East and Africa. Of these, the Americas will command the market over the forecast period. It is predicted to touch USD 689.91 million by 2023. This is owing to investments in R&D, huge demand for organs, presence of developed healthcare infrastructure, and the development of 3D printed pills that are customized as per the body weight and age of the person.
The 3D bioprinting market in the APAC region is predicted to grow at the fastest pace over the forecast period. It is predicted to touch USD 507.18 million at a 27.25% CAGR. This is owing to the abundance of opportunities, development in 3D printing, developments in the healthcare sector, and government funding for accelerating the 3D printing technology pace.
The 3D bioprinting market in Europe is predicted to have a healthy growth over the forecast period. It is predicted to touch USD 649.91 million by 2023. This is owing to increasing focus on health and wellness, increase in cosmetic surgery, and agreements between key players.
Browse Full Report Details at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
